Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Sphingosine-1-phosphate-induced nociceptor excitation and ongoing pain behavior in mice and humans is largely mediated by S1P3 receptor.

Camprubí-Robles M, Mair N, Andratsch M, Benetti C, Beroukas D, Rukwied R, Langeslag M, Proia RL, Schmelz M, Ferrer Montiel AV, Haberberger RV, Kress M.

J Neurosci. 2013 Feb 6;33(6):2582-92. doi: 10.1523/JNEUROSCI.4479-12.2013.

2.

Sphingosine-1-phosphate via activation of a G-protein-coupled receptor(s) enhances the excitability of rat sensory neurons.

Zhang YH, Fehrenbacher JC, Vasko MR, Nicol GD.

J Neurophysiol. 2006 Sep;96(3):1042-52. Epub 2006 May 24.

3.

Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor.

Walter DH, Rochwalsky U, Reinhold J, Seeger F, Aicher A, Urbich C, Spyridopoulos I, Chun J, Brinkmann V, Keul P, Levkau B, Zeiher AM, Dimmeler S, Haendeler J.

Arterioscler Thromb Vasc Biol. 2007 Feb;27(2):275-82. Epub 2006 Dec 7.

4.

Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury.

Means CK, Xiao CY, Li Z, Zhang T, Omens JH, Ishii I, Chun J, Brown JH.

Am J Physiol Heart Circ Physiol. 2007 Jun;292(6):H2944-51. Epub 2007 Feb 9.

5.

High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor.

Theilmeier G, Schmidt C, Herrmann J, Keul P, Schäfers M, Herrgott I, Mersmann J, Larmann J, Hermann S, Stypmann J, Schober O, Hildebrand R, Schulz R, Heusch G, Haude M, von Wnuck Lipinski K, Herzog C, Schmitz M, Erbel R, Chun J, Levkau B.

Circulation. 2006 Sep 26;114(13):1403-9. Epub 2006 Sep 18.

6.

Sphingosine-1-phosphate mediates migration of mature dendritic cells.

Czeloth N, Bernhardt G, Hofmann F, Genth H, Förster R.

J Immunol. 2005 Sep 1;175(5):2960-7.

7.

Involvement of sphingosine-1-phosphate in glutamate secretion in hippocampal neurons.

Kajimoto T, Okada T, Yu H, Goparaju SK, Jahangeer S, Nakamura S.

Mol Cell Biol. 2007 May;27(9):3429-40. Epub 2007 Feb 26.

8.

Involvement of sphingosine 1-phosphate (S1P) receptor type 1 and type 4 in migratory response of mouse T cells toward S1P.

Matsuyuki H, Maeda Y, Yano K, Sugahara K, Chiba K, Kohno T, Igarashi Y.

Cell Mol Immunol. 2006 Dec;3(6):429-37.

9.

Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity.

Arikawa K, Takuwa N, Yamaguchi H, Sugimoto N, Kitayama J, Nagawa H, Takehara K, Takuwa Y.

J Biol Chem. 2003 Aug 29;278(35):32841-51. Epub 2003 Jun 16.

10.

Sphingosine-1-phosphate-induced airway hyper-reactivity in rodents is mediated by the sphingosine-1-phosphate type 3 receptor.

Trifilieff A, Fozard JR.

J Pharmacol Exp Ther. 2012 Aug;342(2):399-406. doi: 10.1124/jpet.112.191585. Epub 2012 May 8.

11.

Edg8/S1P5: an oligodendroglial receptor with dual function on process retraction and cell survival.

Jaillard C, Harrison S, Stankoff B, Aigrot MS, Calver AR, Duddy G, Walsh FS, Pangalos MN, Arimura N, Kaibuchi K, Zalc B, Lubetzki C.

J Neurosci. 2005 Feb 9;25(6):1459-69.

12.

Sphingosine 1-phosphate (S1P) regulates vascular contraction via S1P3 receptor: investigation based on a new S1P3 receptor antagonist.

Murakami A, Takasugi H, Ohnuma S, Koide Y, Sakurai A, Takeda S, Hasegawa T, Sasamori J, Konno T, Hayashi K, Watanabe Y, Mori K, Sato Y, Takahashi A, Mochizuki N, Takakura N.

Mol Pharmacol. 2010 Apr;77(4):704-13. doi: 10.1124/mol.109.061481. Epub 2010 Jan 22.

13.

Electrophysiological and functional effects of sphingosine-1-phosphate in mouse ventricular fibroblasts.

Benamer N, Fares N, Bois P, Faivre JF.

Biochem Biophys Res Commun. 2011 Apr 29;408(1):6-11. doi: 10.1016/j.bbrc.2011.03.072. Epub 2011 Mar 21.

PMID:
21420933
14.

Sphingosine 1-phosphate accelerates wound healing in diabetic mice.

Kawanabe T, Kawakami T, Yatomi Y, Shimada S, Soma Y.

J Dermatol Sci. 2007 Oct;48(1):53-60. Epub 2007 Jul 20.

PMID:
17643267
16.

Sphingosine 1-phosphate regulates matrix metalloproteinase-9 expression and breast cell invasion through S1P3-Gαq coupling.

Kim ES, Kim JS, Kim SG, Hwang S, Lee CH, Moon A.

J Cell Sci. 2011 Jul 1;124(Pt 13):2220-30. doi: 10.1242/jcs.076794. Epub 2011 Jun 7.

17.

Genetic evidence for involvement of neuronally expressed S1P₁ receptor in nociceptor sensitization and inflammatory pain.

Mair N, Benetti C, Andratsch M, Leitner MG, Constantin CE, Camprubí-Robles M, Quarta S, Biasio W, Kuner R, Gibbins IL, Kress M, Haberberger RV.

PLoS One. 2011 Feb 17;6(2):e17268. doi: 10.1371/journal.pone.0017268.

18.

Sphingosine-1-phosphate inhibits high glucose-mediated ERK1/2 action in endothelium through induction of MAP kinase phosphatase-3.

Whetzel AM, Bolick DT, Hedrick CC.

Am J Physiol Cell Physiol. 2009 Feb;296(2):C339-45. doi: 10.1152/ajpcell.00293.2008. Epub 2008 Dec 17.

19.

Contribution of TRPV1 to the bradykinin-evoked nociceptive behavior and excitation of cutaneous sensory neurons.

Katanosaka K, Banik RK, Giron R, Higashi T, Tominaga M, Mizumura K.

Neurosci Res. 2008 Nov;62(3):168-75. doi: 10.1016/j.neures.2008.08.004. Epub 2008 Aug 23.

PMID:
18789982
20.

Mechanisms of the negative inotropic effects of sphingosine-1-phosphate on adult mouse ventricular myocytes.

Landeen LK, Dederko DA, Kondo CS, Hu BS, Aroonsakool N, Haga JH, Giles WR.

Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H736-49. Epub 2007 Nov 16.

Supplemental Content

Support Center